TG Therapeutics Inc (TGTX) — Cash Flow Reinvestment Rate
Latest as of June 2026:
0.08x
TG Therapeutics Inc (TGTX) has a Cash Flow Reinvestment Rate of 0.08x as of June 2026, reinvesting $1.67 Million (capex $344.00K plus investments $1.32 Million) from operating cash flow of $21.37 Million. See TG Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.08x
(Capex + Investments) / Operating CF
Total Reinvested
$1.67 Million
Capex + Investments
Operating Cash Flow
$21.37 Million
USD
Capital Expenditures
$344.00K
USD
Annual Cash Flow Reinvestment Rate for TG Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for TG Therapeutics Inc. See TGTX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow